6 5 Michael Cadier Aesthetic Surgery Limited 07110884 false 2023-07-01 2024-06-30 2024-06-30 The principal activity of the company is aesthetic surgery Digita Accounts Production Advanced 6.30.9574.0 true 07110884 2023-07-01 2024-06-30 07110884 2024-06-30 07110884 bus:OrdinaryShareClass1 2024-06-30 07110884 core:CurrentFinancialInstruments 2024-06-30 07110884 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 07110884 core:Non-currentFinancialInstruments 2024-06-30 07110884 core:Non-currentFinancialInstruments core:AfterOneYear 2024-06-30 07110884 core:Goodwill 2024-06-30 07110884 core:MotorVehicles 2024-06-30 07110884 core:OfficeEquipment 2024-06-30 07110884 bus:SmallEntities 2023-07-01 2024-06-30 07110884 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 07110884 bus:FilletedAccounts 2023-07-01 2024-06-30 07110884 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 07110884 bus:RegisteredOffice 2023-07-01 2024-06-30 07110884 bus:Director1 2023-07-01 2024-06-30 07110884 bus:Director2 2023-07-01 2024-06-30 07110884 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 07110884 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 07110884 bus:Agent1 2023-07-01 2024-06-30 07110884 core:Goodwill 2023-07-01 2024-06-30 07110884 core:FurnitureFittingsToolsEquipment 2023-07-01 2024-06-30 07110884 core:MotorVehicles 2023-07-01 2024-06-30 07110884 core:OfficeEquipment 2023-07-01 2024-06-30 07110884 countries:AllCountries 2023-07-01 2024-06-30 07110884 2023-06-30 07110884 core:Goodwill 2023-06-30 07110884 core:CostValuation 2023-06-30 07110884 core:MotorVehicles 2023-06-30 07110884 core:OfficeEquipment 2023-06-30 07110884 2022-07-01 2023-06-30 07110884 2023-06-30 07110884 bus:OrdinaryShareClass1 2023-06-30 07110884 core:CurrentFinancialInstruments 2023-06-30 07110884 core:CurrentFinancialInstruments core:WithinOneYear 2023-06-30 07110884 core:Non-currentFinancialInstruments 2023-06-30 07110884 core:Non-currentFinancialInstruments core:AfterOneYear 2023-06-30 07110884 core:MotorVehicles 2023-06-30 07110884 core:OfficeEquipment 2023-06-30 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 07110884

Michael Cadier Aesthetic Surgery Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 June 2024

 

Michael Cadier Aesthetic Surgery Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 11

 

Michael Cadier Aesthetic Surgery Limited

Company Information

Directors

Mr M A Cadier

Mrs P J Cadier

Registered office

Suite 204 Warner House
123 Castle Street
Salisbury
Wiltshire
SP1 3TB

Accountants

Ian Sheekey Accountancy Limited Suite 204 Warner House
123 Castle Street
Salisbury
Wiltshire
SP1 3TB

 

Michael Cadier Aesthetic Surgery Limited

(Registration number: 07110884)
Balance Sheet as at 30 June 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

5

33,190

42,782

Investments

6

176,600

176,600

 

209,790

219,382

Current assets

 

Debtors

7

84,501

61,807

Cash at bank and in hand

 

411,146

199,374

 

495,647

261,181

Creditors: Amounts falling due within one year

8

(521,943)

(213,027)

Net current (liabilities)/assets

 

(26,296)

48,154

Total assets less current liabilities

 

183,494

267,536

Creditors: Amounts falling due after more than one year

8

(80,000)

(120,000)

Provisions for liabilities

(8,298)

(10,696)

Net assets

 

95,196

136,840

Capital and reserves

 

Called up share capital

9

100

100

Retained earnings

95,096

136,740

Shareholders' funds

 

95,196

136,840

For the financial year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

 

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Michael Cadier Aesthetic Surgery Limited

(Registration number: 07110884)
Balance Sheet as at 30 June 2024

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 25 March 2025 and signed on its behalf by:
 

.........................................
Mr M A Cadier
Director

 

Michael Cadier Aesthetic Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Suite 204 Warner House
123 Castle Street
Salisbury
Wiltshire
SP1 3TB
England

These financial statements were authorised for issue by the Board on 25 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities.

The company recognises revenue when the amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date.

 

Michael Cadier Aesthetic Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures, fittings & equipment

33% straight line

Motor vehicles

25% reducing balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

10 years straight line

Investments

Investments which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

 

Michael Cadier Aesthetic Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Michael Cadier Aesthetic Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 6 (2023 - 5).

 

Michael Cadier Aesthetic Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 July 2023

250,000

250,000

At 30 June 2024

250,000

250,000

Amortisation

At 1 July 2023

250,000

250,000

At 30 June 2024

250,000

250,000

Carrying amount

At 30 June 2024

-

-

5

Tangible assets

Office equipment
£

Motor vehicles
 £

Total
£

Cost or valuation

At 1 July 2023

4,091

52,090

56,181

Additions

1,704

-

1,704

At 30 June 2024

5,795

52,090

57,885

Depreciation

At 1 July 2023

3,636

9,763

13,399

Charge for the year

714

10,582

11,296

At 30 June 2024

4,350

20,345

24,695

Carrying amount

At 30 June 2024

1,445

31,745

33,190

At 30 June 2023

455

42,327

42,782

6

Investments

2024
£

2023
£

Investments in joint ventures

176,600

176,600

 

Michael Cadier Aesthetic Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

Joint ventures

£

Cost

At 1 July 2023

176,600

Provision

Carrying amount

At 30 June 2024

176,600

At 30 June 2023

176,600

7

Debtors

Current

2024
£

2023
£

Trade debtors

73,050

50,355

Other debtors

11,451

11,452

 

84,501

61,807

 

Michael Cadier Aesthetic Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

8

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Taxation and social security

228,029

25,947

Accruals and deferred income

7,044

6,732

Other creditors

286,870

180,348

521,943

213,027

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

10

80,000

120,000

9

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

       

10

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

80,000

120,000

11

Dividends

 

Michael Cadier Aesthetic Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

2024

2023

£

£

Interim dividend of £7,800.00 (2023 - £6,900.00) per ordinary share

780,000

690,000

 

 

12

Related party transactions

Transactions with directors

Directors' remuneration

The directors' remuneration for the year was as follows:

2024
£

2023
£

Remuneration

11,100

11,100

Contributions paid to money purchase schemes

50,000

41,378

61,100

52,478